1. Home
  2. PTIX vs FMTO Comparison

PTIX vs FMTO Comparison

Compare PTIX & FMTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • FMTO
  • Stock Information
  • Founded
  • PTIX 1994
  • FMTO 2000
  • Country
  • PTIX United States
  • FMTO Israel
  • Employees
  • PTIX N/A
  • FMTO N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • FMTO
  • Sector
  • PTIX Health Care
  • FMTO
  • Exchange
  • PTIX Nasdaq
  • FMTO NYSE
  • Market Cap
  • PTIX 2.0M
  • FMTO 2.3M
  • IPO Year
  • PTIX 2016
  • FMTO N/A
  • Fundamental
  • Price
  • PTIX $0.27
  • FMTO $3.52
  • Analyst Decision
  • PTIX
  • FMTO
  • Analyst Count
  • PTIX 0
  • FMTO 0
  • Target Price
  • PTIX N/A
  • FMTO N/A
  • AVG Volume (30 Days)
  • PTIX 599.7K
  • FMTO 19.3K
  • Earning Date
  • PTIX 03-31-2025
  • FMTO 03-31-2025
  • Dividend Yield
  • PTIX N/A
  • FMTO N/A
  • EPS Growth
  • PTIX N/A
  • FMTO N/A
  • EPS
  • PTIX N/A
  • FMTO N/A
  • Revenue
  • PTIX N/A
  • FMTO $754,768.00
  • Revenue This Year
  • PTIX N/A
  • FMTO N/A
  • Revenue Next Year
  • PTIX N/A
  • FMTO N/A
  • P/E Ratio
  • PTIX N/A
  • FMTO N/A
  • Revenue Growth
  • PTIX N/A
  • FMTO N/A
  • 52 Week Low
  • PTIX $0.25
  • FMTO $3.12
  • 52 Week High
  • PTIX $1.87
  • FMTO $694.45
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 34.94
  • FMTO N/A
  • Support Level
  • PTIX $0.25
  • FMTO N/A
  • Resistance Level
  • PTIX $0.30
  • FMTO N/A
  • Average True Range (ATR)
  • PTIX 0.03
  • FMTO 0.00
  • MACD
  • PTIX 0.00
  • FMTO 0.00
  • Stochastic Oscillator
  • PTIX 10.43
  • FMTO 0.00

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About FMTO FEMTO TECHNOLOGIES INC

Femto Technologies Inc is an integrated software company. It owns and markets Benefit CRM, a proprietary customer relationship management CRM software product enabling small and medium sized businesses to optimize their day to day business activities such as sales management, personnel management, marketing, call center activities, and asset management.

Share on Social Networks: